Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Non-Current Debt (2019 - 2021)

International Stem Cell (ISCO) has disclosed Non-Current Debt for 3 consecutive years, with $476000.0 as the latest value for Q2 2021.

  • On a quarterly basis, Non-Current Debt changed N/A to $476000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was $476000.0, a N/A change, with the full-year FY2020 number at $2.5 million, up 4.43% from a year prior.
  • Non-Current Debt was $476000.0 for Q2 2021 at International Stem Cell, down from $915000.0 in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $2.5 million in Q4 2020 to a low of $476000.0 in Q2 2021.
  • A 3-year average of $1.4 million and a median of $915000.0 in 2021 define the central range for Non-Current Debt.
  • Biggest YoY gain for Non-Current Debt was 4.43% in 2020; the steepest drop was 4.43% in 2020.
  • International Stem Cell's Non-Current Debt stood at $2.4 million in 2019, then increased by 4.43% to $2.5 million in 2020, then tumbled by 80.77% to $476000.0 in 2021.
  • Per Business Quant, the three most recent readings for ISCO's Non-Current Debt are $476000.0 (Q2 2021), $915000.0 (Q1 2021), and $2.5 million (Q4 2020).